Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

KYTHERA BIOPHARMACEUTICALS INC (KYTH)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-14Dec-31-13Dec-31-12Dec-31-11Dec-31-10Dec-31-09
   10-K10-K10-K10-K10-K/AS-1/A
Net income  -135.6-51.9-36.8-11.2-16.0-14.8
Depreciation and amortization   [+]0.30.20.60.10.2161.0
Stock-based compensation  12.46.51.90.91.0506.0
Change in working capital   [+]43.635.76.35.54.3-792.0
Other operating activities  19.7-35.4-4.6-18.012.5-14,703.2
Cash from operations  -59.5-44.9-32.7-22.71.9-14,843.0
   
Capital expenditures  -2.10.0-0.2-0.7-0.1-83.0
Purchases of short-term investments, net  -16.2-56.5  12.7-3,587.0
Cash from investing  -18.3-56.5-0.2-0.712.6-3,670.0
   
Issuance of common stock, net   125.072.5   
Other cash from financing  -4.58.65.136.3 10,005.0
Cash from financing  -4.5133.677.636.30.010,005.0
   
Free cash flow  -61.6-44.9-32.9-23.41.8-14,926.0
        Per share (diluted)  ($2.74)($2.35)($6.68)($16.74)$1.34($10,972.03)
   
Cash paid for interest  0.81.30.1   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy